How does IYXI's PB Ratio compare to its peers?

Insufficient data to calculate IYXI's Price-To-Book Ratio vs. peers for valuation analysis.

How does IYXI's PB Ratio compare vs other companies in the US Pharmaceuticals Industry?

Insufficient data to calculate IYXI's Price-To-Book Ratio vs. industry for valuation analysis.

What is IYXI's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate IYXI's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of IYXI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate IYXI's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

IYXI Stock Overview

Through its wholly-owned subsidiaries, operates as a specialty pharmaceutical company in the United States, Canada, and Europe. More details

IYXI fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Shares are highly illiquid

Latest financial reports are more than a year old

Does not have a meaningful market cap ($53)

My Notes

Capture your thoughts, links and company narrative

Inyx, Inc. Competitors

MJ Holdings

OTCPK:MJNE

US$58.0

PLx Pharma Winddown

OTCPK:PLXP.Q

US$30.0

Plant-Based Investment

OTCPK:CWWB.F

US$27.0

Juva Life

OTCPK:JUVA.F

US$164.0

Price History & Performance

Summary of share price highs, lows and changes for Inyx
Historical stock prices
Current Share Price	US$0.000001
52 Week High	US$0.0001
52 Week Low	US$0.000001
Beta	0
1 Month Change	0%
3 Month Change	n/a
1 Year Change	0%
3 Year Change	n/a
5 Year Change	-99.93%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	IYXI	US Pharmaceuticals	US Market
7D	0%	-0.6%	-0.2%
1Y	0%	3.0%	25.8%

Return vs Industry: IYXI underperformed the US Pharmaceuticals industry which returned 3% over the past year.

Return vs Market: IYXI underperformed the US Market which returned 25.8% over the past year.

Price Volatility

Is IYXI's price volatile compared to industry and market?
IYXI volatility
IYXI Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	10.8%
Market Average Movement	6.4%
10% most volatile stocks in US Market	18.6%
10% least volatile stocks in US Market	3.1%

Stable Share Price: IYXI's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine IYXI's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2000	n/a	n/a	n/a

Inyx, Inc., through its wholly-owned subsidiaries, operates as a specialty pharmaceutical company in the United States, Canada, and Europe. It develops and manufactures prescription and over-the-counter pharmaceutical products. The company manufactures hydrocarbon aerosols, a delivery system for dermatological and topical drug applications; metered dose inhalers that are used for respiratory conditions; dry powdered inhalers used for respiratory ailments; metered dose nasal and throat pumps, and sprays; and sterile salines and injectables.

Inyx, Inc. Fundamentals Summary

How do Inyx's earnings and revenue compare to its market cap?
IYXI fundamental statistics
Market cap	US$53.00
Earnings (TTM)	-US$36.21m
Revenue (TTM)	US$85.04m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is IYXI overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IYXI income statement (TTM)
Revenue	US$85.04m
Cost of Revenue	US$54.85m
Gross Profit	US$30.19m
Other Expenses	US$66.39m
Earnings	-US$36.21m

Last Reported Earnings

Sep 30, 2006

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did IYXI perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/06 02:55
End of Day Share Price	2024/12/31 00:00
Earnings	2006/09/30
Annual Earnings	2005/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Inyx, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution